| |
[SORT BY TITLE] [SORT BY DATE] [SORT BY AUTHOR]
Value of Medicine
- How Obamacare Harms the Poor National Review Online, Avik Roy, 07-30-12
- Innovation, Not Spending Cuts, Improves Health Care Investor's Business Daily, Paul Howard, 01-04-12
- The End of the Age of Lipitor? You'd Better Hope Not. Medical Progress Today, Paul Howard, 11-30-11
- Gates Invests Time, Cash Into Drug Research Washington Examiner, Paul Howard, 11-25-11
- How To Liberate New Frontier Of Modern American Medicine Investor's Business Daily, Douglas Holtz-Eakin, 11-09-11
- Former Obama Adviser Warns of the Perils of Price Controls National Review Online, Paul Howard, 08-17-11
- How To Wreck a Prescription-Drug Program Washington Times, Paul Howard, 07-22-11
- Paul Howard interviews Marc M. Boutin, about PEDUFA and why the FDA needs to re-evaluate the way it approves drugs and medical devices. Podcast: Interview, Paul Howard, July 21, 2011
- High-Priced Cancer Drugs: Are They Worth It? National Review Online, Paul Howard, 07-08-11
- Cancer Revolution Is Possible With More Flexible FDA Washington Examiner, Paul Howard, 06-09-11
- Forest Laboratories and the Facts RealClearMarkets, Diana Furchtgott-Roth, 05-05-11
- Our Health Is Worsening At A Time When Medicine Has Never Been Better Blog Post, David Gratzer, 02-15-11
- A Double Edged Sword for U.S. Healthcare RealClearMarkets, Paul Howard, 12-22-10
- The Right Way to Stop Superbugs New York Post, David Gratzer, 11-12-10
- Causing More Harm than Good: Conflict-of-Interest Rules Thwart Medical Progress Forbes.com, Richard A. Epstein, 10-26-10
- A Question for Doctor Berwick National Review Online, Paul Howard, 08-24-10
- FDA Is Slowing Down Necessary Drugs and Treatments Washington Examiner, Paul Howard, 06-17-10
- The FDA and Methuselah Forbes.com, Peter W. Huber, 04-12-10
- The Blue Pill Or The Red Pill? Forbes.com, Tomas J. Philipson, 01-14-10
|
|
|
